 | Up a level |
Du Puy, R S; Postmus, I; Stott, D J; Blum, Manuel; Poortvliet, R K E; Den Elzen, W P J; Peeters, R P; van Munster, B C; Wolffenbuttel, B H R; Westendorp, R G J; Kearney, P M; Ford, I; Kean, S; Messow, C M; Watt, T; Jukema, J W; Dekkers, O M; Smit, J W A; Rodondi, Nicolas; Gussekloo, J; ... (2018). Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and over. BMC Endocrine Disorders, 18(1), p. 67. BioMed Central 10.1186/s12902-018-0285-8
Segna, D; Bauer, D C; Feller, M; Schneider, C; Fink, H A; Aubert, C E; Collet, T-H; Da Costa, B R; Fischer, K; Peeters, R P; Cappola, A R; Blum, M; van Dorland, H A; Robbins, J; Naylor, K; Eastell, R; Uitterlinden, A G; Rivadeneira Ramirez, F; Gogakos, A; Gussekloo, J; ... (2018). Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts. Journal of internal medicine, 283(1), pp. 56-72. Blackwell Scientific Publications 10.1111/joim.12688
Gencer, B; Moutzouri, E; Blum, M; Feller, M; Collet, T H; Buffle, E; Monney, P; Gabus, V; Muller, H; Kearney, P; Gussekloo, J; Westendorp, R; Scott, D J; Bauer, D C; Rodondi, N (October 2019). P755The impact of levothyroxine on cardiac function in older adults with subclinical hypothyroidism: a randomized clinical trial. European Heart Journal, 40(Supplement_1), p. 359. 10.1093/eurheartj/ehz747.0357
